Aligarh: Over 250 people have registered for the trial of COVID-19 vaccine ‘Covaxin’ at the Jawaharlal Nehru Medical College Hospital of the Aligarh Muslim University.
Principal investigator Prof Mohd Shameem said that all the applications will be screened according to protocol and procedure laid down by the Indian Council of Medical Research (ICMR) before inclusion in the study/trial, reported news agency IANS.
Bharat Biotech’s resource persons will visit AMU shortly for the training of staff for the vaccine trials.
Shameem informed that the Vice-Chancellor Prof Tariq Mansoor had also volunteered for Phase-3 trial of the COVID vaccine.
The registration is moving satisfactory but there is an exclusion as well as inclusion criteria, and other detailed procedural/protocol formalities for the Covaxin trial.
The principal investigator said that written consent and other related formalities will be completed in due course.
Comments are closed.